NDC 59310-610 – Cinqair

Reslizumab 10 mg/mL · Injection, Solution, Concentrate · Intravenous

Human Prescription Drug

Product NDC59310-610

Product details

Brand name
Cinqair
Generic name
Reslizumab
Labeler
Teva Respiratory, LLC
Dosage form
Injection, Solution, Concentrate
Route
Intravenous
Marketing category
BLA · BLA761033
Marketed since
April 18, 2016
Listing expires
December 31, 2027
Pharmacologic class
Interleukin-5 Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Cinqair →

Package NDC codes (1)

Package NDCDescriptionSince
59310-610-311 VIAL, SINGLE-USE in 1 CARTON (59310-610-31) / 10 mL in 1 VIAL, SINGLE-USEApr 18, 2016